Press Releases

• Hotel de Crillon, A Rosewood Hotel, voted as the top luxury hotel in the world
• Asian attractions chosen as best things to do
• Hot springs and ski resorts globally are top-of-mind for travellers
• Singapore dominates the restaurant scene in Asia, with three-Michelin-star Odette as the best fine-dining restaurant in Asia

SHANGHAI, June 8, 2024 /PRNewswire/ -- Leading online travel service provider Trip.com has released its 2024 Trip.Best Global and Asia 100 lists, a... (continue reading...)

WASHINGTON, June 8, 2024 /PRNewswire/ -- The following is a statement from NASA Administrator Bill Nelson on the passing of Apollo astronaut Maj. Gen. (ret.) William "Bill" Anders, who passed away June 7, in San Juan Islands, Washington state, at the age of 90.

"In 1968, as a member of the Apollo 8 crew, as one of the first three people to travel... (continue reading...)

SAN DIEGO, June 08, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of VinFast Auto Ltd. (NASDAQ: VFS; VFSWW) securities: (i) between August 15, 2023 and January 17, 2024, inclusive (the “Class Period”); and/or (ii) pursuant and/or traceable to VinFast’s offering documents issued in connection with the merger consummated on August 14, 2023 with VinFast, Black Spade Acquisition Co., and Nuevo Tech Limited (the... (continue reading...)

NEW YORK, N.Y., June 10, 2024 (SEND2PRESS NEWSWIRE)  Want to know how to downgrade iOS 18 beta to 17? WWDC is kicking off on June 10 and the first iOS 18 Beta is expected to be released soon after. It will feature new accessibility options, app updates, RCS support, and a more customizable Home screen. However, as with all Beta versions, iOS 18 might have bugs, making it necessary to downgrade it. “Most downgrade methods that are available in market result in data... (continue reading...)

SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine

INDIANAPOLIS, June 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide in adults with biopsy-proven metabolic... (continue reading...)